Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Eval Clin Pract. 2010 Oct 6;17(3):429–434. doi: 10.1111/j.1365-2753.2010.01444.x

Table 1.

Controlling for confounders in three study designs

Study design Inherent control for confounders Interpretation of unadjusted effect size Interpretation of adjusted effect size
Randomized Controls for observed and, by assumption, unobserved confounders Effect size is unbiased estimate of unconfounded population effect size Effect size is unbiased estimate of unconfounded population effect size Power of the test of treatment effect may increase*
Case–control Controls for observed confounders on which groups are matched. Does not control for unmatched or unobserved confounders Effect size is unbiased estimate of population effect size if groups are matched on all observed confounders Effect size is unbiased if all observed confounders are adjusted for either by matching or in analysis
Quasi-experimental or observational cohort No inherent control for confounders Effect size is biased, and usually artificially large, except in the rare case in which there are no confounders (observed or unobserved) Effect size is unbiased if adjustment is for all confounders and there are no unobserved confounders
*

In a linear model, this increase in power is due to the potential increase in precision of the effect size estimate. In a non-linear model (e.g. logistic regression, Poisson regression, Cox models), adjustment for covariates in a randomized study cannot increase (and is likely to decrease) the precision of the treatment effect, but it can be expected to increase the treatment effect size in randomized trials, leading to increased power [27,34].